117 related articles for article (PubMed ID: 2581495)
21. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):603-9. PubMed ID: 11401909
[TBL] [Abstract][Full Text] [Related]
22. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract.
Waridel F; Estreicher A; Bron L; Flaman JM; Fontolliet C; Monnier P; Frebourg T; Iggo R
Oncogene; 1997 Jan; 14(2):163-9. PubMed ID: 9010218
[TBL] [Abstract][Full Text] [Related]
23. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
24. Detection of activated ras oncogenes in human thyroid carcinomas.
Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
[TBL] [Abstract][Full Text] [Related]
25. Potential biomarkers for head and neck squamous cell carcinoma.
Brown JJ; Xu H; Nishitani J; Mohammed H; Osborne R; Teklehaimanot S; Gill G; Liu X
Laryngoscope; 2003 Mar; 113(3):393-400. PubMed ID: 12616185
[TBL] [Abstract][Full Text] [Related]
26. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma.
Peters ES; McClean MD; Marsit CJ; Luckett B; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2196-202. PubMed ID: 17119046
[TBL] [Abstract][Full Text] [Related]
27. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
Schäfer R; Geisse S; Willecke K
J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
[TBL] [Abstract][Full Text] [Related]
28. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
Christensen ME
Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
[TBL] [Abstract][Full Text] [Related]
29. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions.
Kim MM; Clinger JD; Masayesva BG; Ha PK; Zahurak ML; Westra WH; Califano JA
Clin Cancer Res; 2004 Dec; 10(24):8512-5. PubMed ID: 15623632
[TBL] [Abstract][Full Text] [Related]
31. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
32. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers.
Grüttgen A; Reichenzeller M; Jünger M; Schlien S; Affolter A; Bosch FX
J Pathol; 2001 Jul; 194(3):311-7. PubMed ID: 11439363
[TBL] [Abstract][Full Text] [Related]
33. [Oncogenic activity of head and neck tumors].
Basterra J; Armengot M; Martorell M; Barona R; Montalt J
An Otorrinolaringol Ibero Am; 1995; 22(2):197-206. PubMed ID: 7778721
[TBL] [Abstract][Full Text] [Related]
34. Head and neck squamous cell carcinoma cell lines as a model system for the study of oncogene expression during tumor progression and metastasis.
Gallick GE; Sacks PG; Maxwell SA; Steck PA; Gutterman JU
Prog Clin Biol Res; 1986; 212():97-111. PubMed ID: 3012576
[No Abstract] [Full Text] [Related]
35. Genetic polymorphisms in the tobacco smoke carcinogens detoxifying enzyme UGT1A7 and the risk of head and neck cancer.
Lacko M; Roelofs HM; te Morsche RH; Voogd AC; Ophuis MB; Peters WH; Manni JJ
Head Neck; 2009 Oct; 31(10):1274-81. PubMed ID: 19360737
[TBL] [Abstract][Full Text] [Related]
36. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
[TBL] [Abstract][Full Text] [Related]
37. Analysis of gene amplification in head-and-neck squamous-cell carcinoma.
Leonard JH; Kearsley JH; Chenevix-Trench G; Hayward NK
Int J Cancer; 1991 Jun; 48(4):511-5. PubMed ID: 2045198
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation.
Ha PK; Tong BC; Westra WH; Sanchez-Cespedes M; Parrella P; Zahurak M; Sidransky D; Califano JA
Clin Cancer Res; 2002 Jul; 8(7):2260-5. PubMed ID: 12114429
[TBL] [Abstract][Full Text] [Related]
39. The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma.
Abou-Elhamd KE; Habib TN
Oral Oncol; 2007 Apr; 43(4):366-72. PubMed ID: 16931118
[TBL] [Abstract][Full Text] [Related]
40. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
Kiefer PE; Bepler G; Kubasch M; Havemann K
Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]